BERLIN (Reuters) – Siemens Healthineers on Wednesday posted better than expected fourth-quarter results helped by its cancer care unit and proposed an unchanged dividend for its fiscal year 2023.
Adjusted earnings before interest and taxes (EBIT) reached 1.013 billion euros ($1.08 billion) in the three months through September on revenue of 6.056 billion, the medical device maker said.
Analysts had expected fourth-quarter adjusted EBIT of 981 million euros on revenue of 5.87 billion, according to a company-provided poll.
Siemens Healthineers said it expects adjusted basic earnings per share to be between 2.10 and 2.30 euros and comparable revenue growth of between 4.5% to 6.5% in its fiscal year 2024.
($1 = 0.9360 euros)
(Reporting by Kirsti Knolle; Editing by Maria Sheahan)
